Filter
2616
Filtered Results: 2616
Text search:
Medical
Products
Management
and
Regulation
Featured
Recommendations
267
New Publications
759
Language
Document type
No document type
1377
Studies & Reports
424
Guidelines
413
Manuals
186
Strategic & Response Plan
138
Training Material
28
Fact sheets
24
Situation Updates
16
Resource Platforms
6
Infographics
3
Online Courses
1
Countries / Regions
Global
103
Kenya
93
India
86
Sierra Leone
65
Western and Central Europe
65
Nigeria
61
Liberia
60
South Africa
55
Ethiopia
47
Ghana
47
Uganda
46
Nepal
38
Zambia
38
Latin America and the Carribbean
37
Africa
37
Rwanda
35
Tanzania
33
Bangladesh
33
Malawi
31
Myanmar / Burma
31
Philippines
29
Ukraine
29
Syria
26
Namibia
26
Congo, Democratic Republic of
23
South–East Asia Region
23
Eastern Europe
21
Indonesia
17
West and Central Africa
17
Asia
17
Guinea
16
Zimbabwe
16
Lesotho
16
Senegal
15
Cambodia
15
Eswatini/ Swaziland
14
Eastern Europe and Central Asia
14
East and Southern Africa
13
Pakistan
12
Botswana
11
Haiti
10
Western Pacific Region
10
Cameroon
9
South Sudan
9
Middle East and North Africa
9
Burkina Faso
8
Mozambique
8
USA
7
Jordan
7
Lebanon
7
Thailand
7
Yemen
7
Moldova
7
Iraq
6
Afghanistan
6
Turkey
6
Sudan
6
Brazil
6
Colombia
6
Venezuela
6
Russia
6
Laos
5
Georgia
5
Mali
4
Somalia
4
Germany
4
Argentina
4
North Macedonia
4
Albania
4
Tajikistan
4
Vietnam
4
Saudi Arabia
3
Egypt
3
China
3
Benin
3
Ecuador
3
Iran
3
Kyrgyzstan
3
Kazakhstan
3
Mauritius
3
Chad
2
Papua New Guinea
2
Central African Republic
2
Peru
2
Croatia
2
El Salvador
2
Bolivia
2
Libya
2
Sri Lanka
2
Chile
2
Paraguay
2
Fiji
2
Bhutan
2
Palestine
2
Timor Leste/ East Timor
2
Qatar
2
Uzbekistan
2
United Kingdom
2
Guinea-Bissau
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Gambia
1
Serbia
1
Burundi
1
Honduras
1
Greece
1
Angola
1
Madagascar
1
Nicaragua
1
Poland
1
Djibouti
1
Armenia
1
Estonia
1
Romania
1
Australia
1
North America
1
Gabon
1
Turkmenistan
1
Japan
1
Denmark
1
France
1
Maldives
1
Tunisia
1
Portugal
1
Spain
1
Morocco
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
999
Clinical Guidelines
190
Public Health
185
Key Resources
135
Women & Child Health
124
Pharmacy & Technologies
58
Capacity Building
37
Toolboxes
COVID-19
208
AMR
154
Mental Health
142
Rapid Response
138
HIV
134
Pharmacy
126
TB
100
Planetary Health
94
Caregiver
88
Ebola
81
Conflict
73
Disability
63
Global Health Education
52
NCDs
44
NTDs
39
Specific Hazards
34
Refugee
32
Natural Hazards
30
Zika
21
Health Financing Toolbox
19
Polio
12
Cholera
8
Social Ethics
6
Typhoon
2
Following review of evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics and Laboratory Strengthening, the World Health Organization (WHO) announces that cur...
The document "Priority medical devices list for the COVID-19 response and associated technical specifications" complements this guideline.
This document provides interim guidance on the quality,...
Supply of essential medicines and health technologies (6 April 2020)
This paper is one of a set of technical guidance papers developed by the WHO Regional Office for Europe to provide practical information ... resources for decision-makers on measures to strengthen the health system response to COVID-19.
The purpose of this paper is to provide WHO Regional Office for Europe Country Offices and Member States with guidance on how to maintain supplies of medicines and health technologies, including devices, diagnostics and blood products, during the COVID-19 outbreak.
The workshop aimed to support countries in the prioritization and acceleration of NCD prevention and management with a specific focus on accelerati...
Action Plan for Implementation of Recommendations from the Evaluation of PAHO's Response to COVID-19
An external team evaluated PAHO’s response to COVID-19 to provide an independent assessment of the Pan American Sanitary Bureau’s (PASB) performance regarding preparedness for and response to the COVID-19 pandemic. The evaluations’ final repor...
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system of indicators that measure important aspects of a country’s pharmaceutical situa...
Benchmarking is a strategic process often used by businesses and institutes to standardize performance in relation to the best practices of their sector. The World Health Organization (WHO) and part...
9 April 2020
WHO has published the guidance “Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected” This document is intended for clinicians taking care of hospitalized adult ... paediatric patients with severe acute respiratory infection (SARI) when COVID-19 infection is suspected. Optimized supportive care should be provided to ensure the best possible chance for survival of COVID-19 patients as described in the WHO guidance:
1. Management of severe COVID-19 requires oxygen therapy and monitoring. Supplemental oxygen therapy should be given immediately to patients with SARI and respiratory distress, hypoxaemia or shock.
2. Management of critical COVID-19 (acute respiratory distress syndrome (ARDS)) requires advanced oxygen/ventilatory support.
Nurses are key players in health promotion and disease prevention and the backbone of health care systems worldwide. Nurses work on the front lines of disease prevention, health promotion, ... health management and are often the unsung heroes in health care facilities and emergency response. Despite the critical role they play in health care, there is a nursing shortage across the world that will affect the delivery of competent nursing care. This document highlights key action points for targeted investment in the nursing workforce and calls on Member States to strengthen nursing within the context of their own country efforts.
In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical ... have led to significant financial hardship for individuals and negatively impacted on healthcare systems’ ability to provide population-wide access to essential medicines.
Pharmaceutical pricing policies need to be carefully planned, carried out, and regularly checked and revised according to changing conditions. Strong, well-thought-out policies can guide well-informed and balanced decisions to achieve affordable access to essential health products.
This guideline replaces the 2015 WHO guideline on country pharmaceutical pricing policies, revised to reflect the growing body of literature since the last evidence review in 2010. This update also recognizes country experiences in managing the prices of pharmaceutical products.
The report aims to help policy-makers and programme managers identify the areas that need attention and to work towards effective implementation and...
Nurses play a key role in the provision of primary health care (PHC) and the coordination and organization of medical care overall. Nurses ar...
This Pharmaceutical Country Profile for Kenya (2010) has been developed by the Ministry of Medical Services with support of the World Health Organization. The Profile contains information on existing socio-economic ... health-related conditions, resources, regulatory structures and processes and outcomes relating to the pharmaceutical sector in Kenya.
This report is primarily intended for the community of policymakers and researchers concerned about the rising risks of domestic, regional, and global infectious disease epidemics, ... the collective failure to take the coordinated actions required to reduce such risks. These risks include the expected health, economic, and societal costs that are borne by countries, regions, and even all nations in the case of pandemics (which are worldwide epidemics). These risks also include the consequences of increasing antimicrobial resistance (AMR) and its spread within regions and globally. A necessary first step is to monitor whether a broad range of stakeholders are acting to prevent outbreaks from becoming epidemics, whether their capacities to respond to epidemics are robust, and whether preparedness to respond to pandemics and limit the resulting economic and health damage is improving. Analyzing the adequacy of these efforts is vitally important for the decisions of policymakers to invest in the public health and disaster-risk management capacities. Early and effective control of disease outbreaks prevents substantial health and economic costs whether or not the disease can spread globally and become a pandemic.
WHO consolidated guidelines on tuberculosis: module 1: prevention: tuberculosis preventive treatment
The 2020 recommendations for the programmatic management of TB preventive treatment are the first to be released under the rubric of WHO consolidated TB guidelines (Module 1 – Prevention). The WHO consolidated TB guidelines will gradually group al...
It outlines key achievements, needs and opportunities for intervention in the field of rehabilitation in Ukraine. The content of this document is a snapshot in time – not an in-depth analysis of the entire rehabilitation sector. The analysis focus...
The overall goal of the programme, to reduce the malaria morbidity and mortality by 75% (using 2012 as baseline) by the year 2020, continued to be pursued in 2014. The following areas were identified as some of the priorities for the year: Malaria C...
This working paper was conceived to offer practical tips and suggestions on how to establish and sustain the multisectoral coordination needed to develop ... implement National Action Plans on AMR (NAPs). It is intended for anyone with responsibility for addressing AMR at country level. Drawing on both the published literature and the operational experience of four ‘focal countries’ (Ethiopia, Kenya, Philippines and Thailand), it summarizes lessons learned and the latest thinking on multisectoral working to achieve effective AMR action. The experience in focal countries points to a number of tools and tactics that can be used to help establish and enhance sustainable multisectoral collaboration for AMR action. These can be grouped into four categories: political commitment, resources, governance mechanisms, and practical management.
The strategy focuses on mobilizing and coordinating partners, experts and resources to help countries enhance surveillance of the Zika virus and di...
8 January 2021
Sequencing enabled the world to rapidly identify SARS-CoV-2 and develop diagnostic tests and other tools for outbreak management. C...
